Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 1, 2005
(September 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Thomas Weisel Partners Healthcare Conference, which is being held September 7 - 9 in...
-
Aug 16, 2005
(August 16, 2005)
-
Aug 9, 2005
(August 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) approval for the...
-
Aug 2, 2005
(August 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the initial activation of bilateral cochlear implants for 14-month-old identical-twin girls at the California Ear...
-
Jul 28, 2005
(July 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the 2005 Best Practices in Logistics Management Gold Award from Logistics Management magazine, a...
-
Jul 19, 2005
(July 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its second quarter ended June 30, 2005. Highlights: Net sales of $1.6 billion, an increase of 11...
-
Jul 11, 2005
(July 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that physicians have implanted the 1,000th Precision™ Spinal Cord Stimulation System for the treatment of chronic...
-
Jul 8, 2005
(July 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Matrix2™ 360o Detachable Coils, which have been cleared by the U.S. Food and Drug...
-
Jul 7, 2005
(July 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2005 on Tuesday, July 19, at 11:00...
-
Jul 1, 2005
(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...
-
Jun 27, 2005
(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...
-
Jun 24, 2005
(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...
-
Jun 21, 2005
(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...
-
Jun 20, 2005
(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...
-
Jun 14, 2005
(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...
-
Jun 9, 2005
(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....
-
Jun 9, 2005
(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...
-
Jun 2, 2005
(June 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of the cash tender offer for any and all outstanding shares of common stock of Rubicon Medical...
-
Jun 1, 2005
(June 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that Lucia Luce Quinn has been appointed Executive Vice President of Human Resources. She will be responsible for...
-
May 26, 2005
and Paris, France (May 26, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has enrolled its 400th patient in the world
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided updated financial estimates for 2005. The Company announced the estimates at a meeting of financial...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the efficacy of...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced thirty-day safety data from its ATLAS clinical trial. ATLAS is the first trial using Boston...
-
May 25, 2005
and Paris, France (May 25, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced results from its ARRIVE and Milestone II registries. The results were announced during a symposia...
-
May 24, 2005
and Paris, France (May 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS VI clinical trial. The data demonstrated that the safety and...